WuXi AppTec Co., Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WUXIF research report →
Companywww.wuxiapptec.com
WuXi AppTec Co. , Ltd. , an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally.
- CEO
- Ge Li
- IPO
- 2020
- Employees
- 39,414
- HQ
- Shanghai, CN
Price Chart
Valuation
- Market Cap
- $41.41B
- P/E
- 15.52
- P/S
- 5.48
- P/B
- 3.71
- EV/EBITDA
- 8.62
- Div Yield
- 0.33%
Profitability
- Gross Margin
- 49.24%
- Op Margin
- 42.66%
- Net Margin
- 41.74%
- ROE
- 27.31%
- ROIC
- 17.53%
Growth & Income
- Revenue
- $45.46B · 15.84%
- Net Income
- $19.15B · 102.65%
- EPS
- $6.70 · 104.27%
- Op Income
- $17.00B
- FCF YoY
- 38.82%
Performance & Tape
- 52W High
- $16.80
- 52W Low
- $7.34
- 50D MA
- $13.88
- 200D MA
- $14.24
- Beta
- 0.56
- Avg Volume
- 386.368
Get TickerSpark's AI analysis on WUXIF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our WUXIF Coverage
We haven't published any research on WUXIF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WUXIF Report →